SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-02-024380
Filing Date
2002-06-14
Accepted
2002-06-14 17:27:45
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G a2082466zsc13g.htm SC 13G 8866
3 EXHIBIT 1 a2082466zex-1.htm EX-1 9652
  Complete submission text file 0000912057-02-024380.txt   20877
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 3520 DUNHILL STREET SAN DIEGO CA 92121
Business Address 3520 DUNHILL STREET SAN DIEGO CA 92121 5855974990
APPLIED MOLECULAR EVOLUTION INC (Subject) CIK: 0001111312 (see all company filings)

IRS No.: 330374014 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59733 | Film No.: 02679995
SIC: 8731 Services-Commercial Physical & Biological Research